Spain Large Molecule Bioanalytical Testing Services Market Size & Outlook
Related Markets
Spain large molecule bioanalytical testing services market highlights
- The Spain large molecule bioanalytical testing services market generated a revenue of USD 63.2 million in 2024 and is expected to reach USD 109.3 million by 2030.
- The Spain market is expected to grow at a CAGR of 9.5% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2024.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Large molecule bioanalytical testing services market data book summary
| Market revenue in 2024 | USD 63.2 million |
| Market revenue in 2030 | USD 109.3 million |
| Growth rate | 9.5% (CAGR from 2025 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Preclinical |
| Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Spain accounted for 3.0% of the global large molecule bioanalytical testing services market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany large molecule bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 183.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Large Molecule Bioanalytical Testing Services Market Scope
Large Molecule Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Toxikon | View profile | 101-250 | Bedford, Massachusetts, United States, North America | http://www.toxikon.com/ |
| Pace Analytical Services | View profile | 11-50 | Woburn, Massachusetts, United States, North America | https://www.pacelifesciences.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Spain large molecule bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 73.89% in 2024. Horizon Databook has segmented the Spain large molecule bioanalytical testing services market based on clinical, preclinical covering the revenue growth of each sub-segment from 2018 to 2030.
The Spanish large molecule bioanalytical testing market is driven by the growing number of clinical trials in the country. For instance, Spain conducted 23,369 clinical trials between 1999 and 2019, according to WHO’s ICTRP. This contributes for over 4% of total clinical trials conducted globally in the same period.
Furthermore, according to Eurostat, the healthcare expenditure of Spain was 8.9% of its GDP in 2017. Rising healthcare expenditure will drive the large molecule bioanalytical testing market as well. In 2019, the Spanish Pharmaceutical R&D expenditure rose by 5.2%. The rising pharmaceutical R&D expenditure in the country will also boost market growth.
Furthermore, high geriatric population will augment the need for advanced health care services, driving the Spanish market. For instance, according to OECD, 19.3% of the Spanish population was aged 65 or above in 2018.
Reasons to subscribe to Spain large molecule bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain large molecule bioanalytical testing services market databook
-
Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Spain large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)
Spain Large Molecule Bioanalytical Testing Services Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
